Repros Therapeutics

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Repros Therapeutics ( RPRX) is a development-stage biopharmaceutical company focused on the development of new drugs to treat hormonal and reproductive system disorders. This stock is trading up 11.2% at $10.60 in recent trading.

Today's Volume: 431,000

Average Volume: 218,202

Volume % Change: 355%

From a technical perspective, RPRX is skyrocketing today with heavy volume, and this move has pushed the stock into breakout territory since it's taken out some near-term overhead resistance levels at $9.58 to $9.94.

>>5 Biotech Stocks Under $5 Blasting Off

Traders should now look for long-biased trades in RPRX as long as its trending above today's low of $9.53 with strong upside volume flows. I would consider any upside volume day that registers near or above 218,202 shares as bullish. If we continue to see RPRX hold that trend, then this stock could easily be setting up to trade higher towards $15 a share in the near future.

On the flipside, I would avoid this stock or look for short-biased trades if it fails to hold this breakout, and then drops back below some major near-term support at $8.79 with high volume.

If you liked this article you might like

Biotech Stock Mailbag: Do Investors Have an 'Aphinity' for Shorting Puma Into Trial Results?

8 Stocks Under $10 to Trade for Huge Profits

5 Stocks Under $10 Set to Soar

Repros (RPRX) Stock Plummets After FDA Rejects Hypogonadism Drug Trial Results

4 Stocks Under $10 to Trade for Big Breakouts